je.st
news
Tag: melanoma
Death sentence no longer a given for melanoma patients Death sentence ...
2013-06-06 09:26:01| Biotech - Topix.net
Nathan Schwegman was just 25 when his doctor told him he had a 3 percent chance of surviving the melanoma that had spread into his lungs and spine, soon leaving him in so much pain he could hardly move.
Tags: longer
death
patients
sentence
Merck melanoma drug shrinks tumors in 38 percent of patients
2013-06-02 18:54:47| Biotech - Topix.net
A Merck & Co drug designed to unmask tumor cells and mobilize the immune system into fighting cancer helped shrink tumors in 38 percent of patients with advanced melanoma in an early-stage study, U.S. researchers said on Sunday.
Tags: of
drug
percent
patients
Merck Announces Presentation of Interim Data from Study Evaluating Lambrolizumab, an Investigational Anti-PD-1 Antibody, in Patients with Advanced Melanoma at ASCO 2013
2013-06-02 17:15:00| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION, N.J. -Merck Expands Lambrolizumab Clinical Development Program- -Study Published Online in the New England Journal of Medicine- WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the presentation of preliminary results from an ongoing Phase IB expansion study evaluating the safety and efficacy of lambrolizumab (MK-3475), Mercks investigational antibody therapy targeting PD-1, in patients with advanced (inoperable and metastatic) melanoma. Language: English Contact HTML: MerckMedia Contacts:Ian McConnell, 973-901-5722Cathy Cantone, 908-327-3013orInvestor Contacts:Carol Ferguson, 908-500-1101Justin Holko, 609-915-8293 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: data
advanced
study
presentation
Drug Combo May Boost Melanoma Survival, Lessen Side Effects
2013-06-02 13:30:20| Biotech - Topix.net
Adding a white-blood cell boosting treatment from Sanofi to Bristol-Myers Squibb Co.
Tags: side
effects
drug
survival
Bristol-Myers Squibb drug study showed effectiveness against advanced melanoma cancer
2013-05-18 18:06:01| Biotech - Topix.net
Two drugs from Bristol-Myers Squibb Co. shrank tumors in as many as half of patients with advanced melanoma, according to early research that may pave the way for cocktails that trigger the immune system to destroy cancer.
Tags: advanced
study
drug
showed
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] next »